Cork University Maternity Hospital
- Address
- Wilton Road, T12 YE02 Cork, Ireland
Cork University Maternity Hospital - Neonatal Research Center
Cork University Maternity Hospital is a leading research institution specializing in neonatal and perinatal medicine, with particular expertise in the care of premature and critically ill newborns. The center conducts groundbreaking clinical trials focused on improving outcomes for extremely vulnerable infant populations, including those born at the earliest gestational ages and those experiencing life-threatening complications.
- Neonatal resuscitation strategies and oxygen therapy optimization for extremely premature infants (23-28 weeks' gestation)
- Patent Ductus Arteriosus (PDA) management and prevention of complications in extremely low birth weight infants
- Hypoxic-Ischemic Encephalopathy (HIE) treatment with neuroprotective therapies
- Chronic lung disease and bronchopulmonary dysplasia (BPD) prevention in preterm neonates
The center's research portfolio demonstrates a comprehensive approach to addressing the most critical challenges in neonatal intensive care, from immediate delivery room interventions to long-term neurodevelopmental outcomes. Their trials investigate innovative pharmacological interventions, including targeted treatments for cardiac complications and neuroprotective agents, with rigorous assessment of safety profiles and therapeutic efficacy. The hospital's commitment to evidence-based neonatal care extends beyond immediate survival to encompass quality of life and developmental outcomes at 18-24 months corrected age.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Ohb Neonatology Limited1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cork University Maternity Hospital
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Mecasermin Rinfabate for the Prevention of Bronchopulmonary Dysplasia in Extremely Premature Neonates: A Randomized, Open-label, Phase 2b Study | Ohb Neonatology Limited | Phase II | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cemiplimab | 1 | Unknown | 2020-02-12 | 2020-02-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.